By Brandon Salter Michael Brady Lynch Firm August 1, 2022 (Mass Tort News) - 2022 has been a momentous year for Multi-district Litigation, particularly in pharmaceutical MDLs such as Zantac, Valsartan, Elmiron, Taxotere, Nexium & Prilosec. It is expected that some of these cases will go to trial in the year 2023; however, the best is yet to come with new … [Read more...] about NEW MDL LITIGATION ON THE HORIZON
Elmiron
ELMIRON LITIGATION: EMERGING TORTS
By Rachel Shkolnik, Hunter J. Shkolnik Napoli Shkolnik, PLLC (May 27, 2020) The nationwide Elmiron eye damage litigation has picked up headlines over the past several months. Elmiron, the brand name for pentosan polysulfate sodium, is a semi-synthetically produced heparin-like macromolecular carbohydrate derivative.[1] The lawsuit is centralized around the basis that … [Read more...] about ELMIRON LITIGATION: EMERGING TORTS